> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Dentsply Sirona Earnings Fall To $0.29 A Share Despite $39 Million Accounting Benefit
- URL: https://www.bullished.co/dentsply-sirona-earnings-fall-to-0-29-a-share-despite-39-million-accounting-benefit-6fa69bf2/
- Published: 2026-11-06T13:56:00.000Z
- Updated: 2026-11-06T13:56:00.000Z
- Description: Dental sales weakened across all three businesses, while Wellspect posted record quarterly sales and free cash flow fell to zero.
- Author: Matteo Parrino
- Tags: Earnings, XRAY, Industry: Healthcare

[Dentsply Sirona](https://www.bullished.co/tag/xray/), which makes dental equipment, implants, clear aligners and consumables, reported third-quarter [adjusted earnings](https://www.globenewswire.com/news-release/2026/11/05/3396986/0/en/dentsply-sirona-reports-third-quarter-2026-results.html?ref=bullished.co) of $0.29 a share Thursday, down from $0.42 a year earlier despite a $39 million inventory-accounting benefit. Sales fell to $836 million from $904 million, down 7.6% as reported and 7.0% excluding currency changes, according to results furnished with its [SEC filing](https://www.sec.gov/Archives/edgar/data/0000818479/000081847926000285/xray-20261105.htm?ref=bullished.co).

## An Earnings Lift That Won’t Repeat

The [$39 million benefit](https://www.sec.gov/Archives/edgar/data/0000818479/000081847926000285/dentsply8kq32026ex991.htm?ref=bullished.co) came from changing the estimate used to remove unrealized profit from inventory. The revision captured a cumulative effect, reduced the reported net loss and added approximately $30 million to adjusted net income. The company said it does not expect equivalent benefits in future periods.

Even with that help, adjusted net income was $59 million, versus $84 million a year earlier. Adjusted earnings per share [declined 29.4%](https://www.globenewswire.com/news-release/2026/11/05/3396986/0/en/dentsply-sirona-reports-third-quarter-2026-results.html?ref=bullished.co). Adjusted earnings before interest, taxes, depreciation and amortization fell 13.3% to $146 million, and the margin on that measure slipped to 17.3% from 18.4%.

Under standard accounting, the loss attributable to shareholders was $2 million, or $0.01 a share, compared with $427 million, or $2.14 a share, a year earlier. Goodwill and intangible-asset impairment charges were $3 million, versus $262 million in the prior-year quarter. Gross margin rose to 52.9% from 48.8%; the adjusted gross margin was 54.5%, versus 52.6%.

## Wellspect Grows, Dental Businesses Shrink

Wellspect Healthcare delivered record quarterly sales of $92 million, up from $83 million. Growth was 10.1% as reported and 11.0% excluding currency movements. The company also launched the Surity Urinary Management System, completing its U.S. Surity portfolio.

The dental businesses moved the other way:

- Connected Technology Solutions generated $230 million, versus $259 million, down 11.0% as reported and 10.1% excluding currency changes.
- Essential Dental Solutions generated $343 million, versus $357 million, down 4.0% as reported and 3.6% excluding currency changes.
- Orthodontic and Implant Solutions generated $171 million, versus $205 million, down 16.6% as reported and 16.2% excluding currency changes.

Dentsply Sirona serves dentists and dental laboratories with products ranging from imaging systems and intraoral scanners to implants and clear aligners. Wellspect supplies continence-care products for urological and bowel management. About two-thirds of the company’s dental consumable, technology and equipment products reach customers through third-party distributors.

Dan Scavilla, president and CEO of Dentsply Sirona, pointed to progress in implants and endodontics and an expanded U.S. dealer network. Describing the company’s return-to-growth plan, he said, “[our focus is now on execution](https://www.sec.gov/Archives/edgar/data/0000818479/000081847926000285/dentsply8kq32026ex991.htm?ref=bullished.co),” with sales-force, clinical-education and innovation efforts central to that work.

## Zero Free Cash Flow, Continued Buybacks

Third-quarter [free cash flow](https://www.sec.gov/Archives/edgar/data/0000818479/000081847926000285/dentsply8kq32026ex991.htm?ref=bullished.co)—cash left after capital spending—was zero, versus $40 million a year earlier. Operating cash flow fell to $32 million from $79 million, primarily because of unfavorable working-capital changes, while capital spending was $32 million.

The company nevertheless bought back 1.2 million shares for approximately $13 million during the quarter. Repurchases totaled $25 million for the first nine months of 2026\. Cash and equivalents stood at $195 million on September 30, compared with $326 million at the end of 2025.

Dentsply Sirona’s updated full-year outlook calls for approximately [$3.5 billion](https://www.benzinga.com/news/26/11/62958399/dentsply-sirona-q3-2026-earnings-call-transcript?ref=bullished.co) in sales and adjusted earnings of $1.20 to $1.30 a share, excluding a $0.17 one-time tariff-refund benefit.

Learn

- [Item 2.02: results of operations →](https://www.bullished.co/learn/8-k-items-explained/#item-202-results-of-operations)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — DENTSPLY SIRONA Inc. (XRAY)](https://www.sec.gov/Archives/edgar/data/0000818479/000081847926000285/xray-20261105.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit dentsply8kq32026ex991.htm — DENTSPLY SIRONA Inc. 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0000818479/000081847926000285/dentsply8kq32026ex991.htm?ref=bullished.co) — SEC EDGAR
- [Dentsply Sirona Q3 2026 Earnings Call Transcript](https://www.benzinga.com/news/26/11/62958399/dentsply-sirona-q3-2026-earnings-call-transcript?ref=bullished.co) — benzinga.com
- [Dentsply Sirona Reports Third Quarter 2026 Results](https://www.globenewswire.com/news-release/2026/11/05/3396986/0/en/dentsply-sirona-reports-third-quarter-2026-results.html?ref=bullished.co) — globenewswire.com

### More on Dentsply Sirona

- [Dentsply's $39 Million Inventory Accounting Gain Lifted The Quarter, And The CFO Says It Won't Recur](https://www.bullished.co/dentsplys-39-million-inventory-accounting-gain-lifted-the-quarter-and-the-cfo-says-it-wont-d4e7670a/)
- [Dentsply Sirona Gets Lenders And Noteholders To Raise Leverage Caps For Two Quarters, In Exchange For Lien And Payout Limits](https://www.bullished.co/dentsply-sirona-gets-lenders-and-noteholders-to-raise-leverage-caps-for-two-quarters-in-d2ac1a22/)

[All Dentsply Sirona (XRAY) coverage →](https://www.bullished.co/tag/xray/)